Novo releases GLP-1 pill, bitcoin price rises, Qualcomm’s chips

January 5, 2026

Market Domination host Josh Lipton outlines three of the top stories investors are watching on Monday: Novo Nordisk’s (NVO) launching its GLP-1 pill, bitcoin’s (BTC-USD) bullish start to 2026, and Qualcomm’s (QCOM) CES announcements.

To watch more expert insights and analysis on the latest market action, check out more Market Domination.

00:03 Speaker A

All right, time for some of today’s trending tickers. We’re going to start off here on Novo Nordis.

00:09 Speaker A

Those shares moving higher after launching the first ever GLP-1 pill for obesity in the US, marking a major shift in the weight loss drug market.

00:23 Speaker A

The oral version of Vagovi is rolling out nationwide at more than 70,000 pharmacies with cash prices starting at $149 a month.

00:32 Speaker A

That’s below the list price of injectable GLP-1s.

00:37 Speaker A

Taking a look over at Bitcoin as well. Prices climbing back here above 94,000, signaling what some analysts see as a renewed bullish turn to start 2026.

00:46 Speaker A

Crypto research firm 10X says trading volumes are normalizing and institutional positioning is beginning to rebuild after a rough end to 2025.

00:57 Speaker A

And finally, let’s take a look over at Qualcomm too. Those shares gaining in today’s trade. The company unveiling new hardware at CES as it pushes deeper into the PC and AI markets.

01:06 Speaker A

Qualcomm also announcing a humanoid robotics initiative and projecting that market could reach $1 trillion by 2040.

Terms and Privacy Policy


 

Search

RECENT PRESS RELEASES